Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database

PURPOSE: Triple negative breast cancer (TNBC) patients frequently receive neoadjuvant chemotherapy (NAC). Only 50% will achieve pathological complete response (pCR). In this retrospective study, we evaluated TNBC outcomes with NAC vs. AC. METHODS: Patients with stages II and III TNBC treated with NA...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagegni, Nusayba A., Tao, Yu, Ademuyiwa, Foluso O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752843/
https://www.ncbi.nlm.nih.gov/pubmed/31536530
http://dx.doi.org/10.1371/journal.pone.0222358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752843/
https://www.ncbi.nlm.nih.gov/pubmed/31536530
http://dx.doi.org/10.1371/journal.pone.0222358

Ejemplares similares